Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery

This study is phase 3 study for prevention of VTE in patients with abdominal surgery.

Inclusion criteria:

• Patients aged >=40 years undergoing the following abdominal (diaphragm to pelvic floor) surgery under general anesthesia lasting more than 45 minutes.
• General or urologic surgery
• Cancer surgery
• Gynecologic surgery
• Radical surgery for pelvic malignancy

Exclusion criteria:

• Active, clinically significant bleeding Thrombocytopenia Body weight <40kg